Literature DB >> 8739077

Regularity and length of menstrual cycles in women aged 41-46 in relation to breast cancer risk: results from the DOM-project.

I den Tonkelaar1, F de Waard.   

Abstract

The effect of regularity and length of the menstrual cycle on breast cancer risk was studied prospectively in 78 cases and 383 age-matched controls who participated in a breast cancer screening programme, the DOM-project, in Utrecht, the Netherlands. Before entering the screening programme when they were aged 41-46, the women kept a menstrual calendar during at least three consecutive cycles. Cycles were considered to be irregular if any of three cycles was shorter than 21 days or longer than 35 days and/or if variation between cycle lengths was more than five days. Women with irregular cycles had a significantly reduced risk of breast cancer (odds ratio = 0.44; 95% confidence interval 0.22-0.86) after adjustment for age at menarche, age at first birth, parity, Quetelet's index and family history of breast cancer. Among regularly menstruating women, long cycles (28 days or more) were not significantly associated with increased risk of breast cancer (odds ratio 1.17; 95% confidence interval 0.66-2.09). To the extent that irregular menstrual cycles reflect anovulatory cycles, our findings support the hypothesis that the cumulative number of regular ovulatory cycles increases breast cancer risk.

Entities:  

Mesh:

Year:  1996        PMID: 8739077     DOI: 10.1007/bf01806143

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  29 in total

1.  Inadequate corpus luteum function: a pathophysiological interpretation of human breast cancer epidemiology.

Authors:  B M Sherman; S G Korenman
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

2.  Menopause and breast cancer risk.

Authors:  D Trichopoulos; B MacMahon; P Cole
Journal:  J Natl Cancer Inst       Date:  1972-03       Impact factor: 13.506

3.  Lifelong menstrual pattern and risk of breast cancer.

Authors:  F Parazzini; C La Vecchia; E Negri; S Franceschi; L Tozzi
Journal:  Oncology       Date:  1993 Jul-Aug       Impact factor: 2.935

4.  Cyclic ovarian function and breast cancer.

Authors:  B M Sherman; R B Wallace; J A Bean
Journal:  Cancer Res       Date:  1982-08       Impact factor: 12.701

5.  Hormonal characteristics of the human menstrual cycle throughout reproductive life.

Authors:  B M Sherman; S G Korenman
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

6.  A prospective study on corpus luteum function and breast cancer risk.

Authors:  I den Tonkelaar; M A Blankenstein; H J Collette; F de Waard; J H Thijssen
Journal:  Gynecol Endocrinol       Date:  1989       Impact factor: 2.260

7.  Menstrual cycle patterns and the risk of breast disease.

Authors:  C La Vecchia; A Decarli; S di Pietro; S Franceschi; E Negri; F Parazzini
Journal:  Eur J Cancer Clin Oncol       Date:  1985-04

8.  Risk factors of breast cancer in Finland.

Authors:  I Soini
Journal:  Int J Epidemiol       Date:  1977-12       Impact factor: 7.196

9.  The influence of medical conditions associated with hormones on the risk of breast cancer.

Authors:  M Moseson; K L Koenig; R E Shore; B S Pasternack
Journal:  Int J Epidemiol       Date:  1993-12       Impact factor: 7.196

10.  Absence of association between reproductive variables and the risk of breast cancer in young women in Sweden and Norway.

Authors:  H O Adami; R Bergström; E Lund; O Meirik
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

View more
  9 in total

1.  Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women.

Authors:  F Clavel-Chapelon
Journal:  Cancer Causes Control       Date:  2002-11       Impact factor: 2.506

2.  A case-control study of menstrual factors in relation to breast cancer risk in African-American women.

Authors:  Jessica S B Beiler; Kangmin Zhu; Sandra Hunter; Kathleen Payne-Wilks; Chanel L Roland; Vernon M Chinchilli
Journal:  J Natl Med Assoc       Date:  2003-10       Impact factor: 1.798

3.  Estrous cycle regulation of mammary epithelial cell proliferation, differentiation, and death in the Sprague-Dawley rat: a model for investigating the role of estrous cycling in mammary carcinogenesis.

Authors:  P Schedin; T Mitrenga; M Kaeck
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-04       Impact factor: 2.673

4.  Menstrual cycle characteristics and incidence of premenopausal breast cancer.

Authors:  Kathryn L Terry; Walter C Willett; Janet W Rich-Edwards; David J Hunter; Karin B Michels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-06       Impact factor: 4.254

5.  Body silhouette, menstrual function at adolescence and breast cancer risk in the E3N cohort study.

Authors:  B Tehard; R Kaaks; F Clavel-Chapelon
Journal:  Br J Cancer       Date:  2005-06-06       Impact factor: 7.640

6.  Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implications.

Authors:  Zsuzsanna Suba
Journal:  Onco Targets Ther       Date:  2014-01-23       Impact factor: 4.147

7.  Reproductive risk factors associated with breast cancer in women in Bangui: a case-control study.

Authors:  Augustin Balekouzou; Ping Yin; Christian Maucler Pamatika; Cavin Epie Bekolo; Sylvain Wilfrid Nambei; Marceline Djeintote; Komlan Kota; Christian Diamont Mossoro-Kpinde; Chang Shu; Minghui Yin; Zhen Fu; Tingting Qing; Mingming Yan; Jianyuan Zhang; Shaojun Chen; Hongyu Li; Zhongyu Xu; Boniface Koffi
Journal:  BMC Womens Health       Date:  2017-03-06       Impact factor: 2.809

Review 8.  The Menstrual Cycle and Risk of Breast Cancer: A Review.

Authors:  Håkan Lars Olsson; Mona Landin Olsson
Journal:  Front Oncol       Date:  2020-01-24       Impact factor: 6.244

Review 9.  Circulatory estrogen level protects against breast cancer in obese women.

Authors:  Zsuzsanna Suba
Journal:  Recent Pat Anticancer Drug Discov       Date:  2013-05       Impact factor: 4.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.